Anesthesia; Adverse Effect
Conditions
Keywords
Post-anesthesia care unit, Risk factors, Pediatrics
Brief summary
The purpose of this study is to determine which factors contribute to prolonged stay of children in the PACU.
Detailed description
Studying the factors associated with prolonged stay of children in the PACU is of great significance to the medical team, as it can improve the quality and speed of anesthesia recovery, not only in line with the concept of accelerated rehabilitation surgery, but also through intervention and optimization of specific factors to improve the efficiency of children's postoperative discharge from the PACU, reduce the incidence of complications, lower medical costs, and increase patient and family satisfaction. Therefore, this study aims to explore the factors associated with prolonged stay of children in the PACU through retrospective analysis.
Interventions
None listed
Sponsors
Saiqiang Guo
Study design
Observational model
COHORT
Time perspective
RETROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
No minimum to 18 Years
Inclusion criteria
* Children aged 0-18 years old; Child entering the Pediatric Post-Anesthesia Care. * Emergency surgery; Pediatric patients with incomplete medical history; Pediatric patients requiring postoperative ICU care; Pediatric patients with preoperative altered consciousness; Neurological disorders; Severe liver, kidney, lung, and heart diseases.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Anesthesia Plan Selection | Day 1 | Anesthesia options include general anesthesia, combined anesthesia, pure intravenous anesthesia, and nerve block anesthesia. |
| Pain Score | Day 1 | Evaluate pain using the Visual Analog Scale (VAS): 0 points: no pain; 1-3 points: mild pain; 4-6 points: moderate pain; 7-10 points: severe pain. |
| Complications in PACU | Day 1 | Nausea, vomiting, chills, pain, agitation |
| American Society of Anesthesiologists（ASA） | Day 1 | ASA I: Patients in good health, without systemic disease. ASA II: Patients with mild systemic disease, not significantly limiting daily activity. ASA III: Patients with severe systemic disease, with definite functional limitation. ASA IV: Patients with severe systemic disease that is a constant threat to life. ASA V: Moribund patients who are not expected to survive without the operation. ASA VI: Brain-dead patients whose organs are being removed for donation. |
| The medication usage in PACU | Day 1 | Morphine, Propofol, Ketorolac, Fentanyl |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| The use of PCA（Patient-Controlled Analgesia）in PACU | Day 1 | PCA usage statistics，yes or no |
Outcome results
None listed